Advertisement

Index by author

August 01, 1990; Volume 38,Issue 2

A

  1. Aicher, L D

    1. Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide.
      J S Woods, C A Calas, L D Aicher, B H Robinson and C Mailer
      Molecular Pharmacology August 1990, 38 (2) 253-260;
    2. Stimulation of porphyrinogen oxidation by mercuric ion. II. Promotion of oxidation from the interaction of mercuric ion, glutathione, and mitochondria-generated hydrogen peroxide.
      J S Woods, C A Calas and L D Aicher
      Molecular Pharmacology August 1990, 38 (2) 261-266;

B

  1. Baker, R M

    1. Characterization of auromomycin-resistant hamster cell mutants that display a multidrug resistance phenotype.
      F J Rauscher, T A Beerman and R M Baker
      Molecular Pharmacology August 1990, 38 (2) 198-206;

  2. Barrett, R W

    1. Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
      U G Klueppelberg, X Molero, R W Barrett and L J Miller
      Molecular Pharmacology August 1990, 38 (2) 159-163;

  3. Barrington, W W

    1. Glycoprotein nature of the A2-adenosine receptor binding subunit.
      W W Barrington, K A Jacobson and G L Stiles
      Molecular Pharmacology August 1990, 38 (2) 177-183;

  4. Bauce, L

    1. Kainate receptors coupled to the evoked release of [3H]-gamma-aminobutyric acid from striatal neurons in primary culture: potentiation by lithium ions.
      S Weiss, D E Kemp, L Bauce and F W Tse
      Molecular Pharmacology August 1990, 38 (2) 229-236;

  5. Beerman, T A

    1. Characterization of auromomycin-resistant hamster cell mutants that display a multidrug resistance phenotype.
      F J Rauscher, T A Beerman and R M Baker
      Molecular Pharmacology August 1990, 38 (2) 198-206;

  6. Benishin, C G

    1. Potassium channel blockade by the B subunit of beta-bungarotoxin.
      C G Benishin
      Molecular Pharmacology August 1990, 38 (2) 164-169;

  7. Boulanger, C

    1. Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance.
      T J Resink, T Scott-Burden, C Boulanger, E Weber and F R Bühler
      Molecular Pharmacology August 1990, 38 (2) 244-252;

  8. Brian, W R

    1. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;

  9. Bühler, F R

    1. Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance.
      T J Resink, T Scott-Burden, C Boulanger, E Weber and F R Bühler
      Molecular Pharmacology August 1990, 38 (2) 244-252;

C

  1. Calas, C A

    1. Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide.
      J S Woods, C A Calas, L D Aicher, B H Robinson and C Mailer
      Molecular Pharmacology August 1990, 38 (2) 253-260;
    2. Stimulation of porphyrinogen oxidation by mercuric ion. II. Promotion of oxidation from the interaction of mercuric ion, glutathione, and mitochondria-generated hydrogen peroxide.
      J S Woods, C A Calas and L D Aicher
      Molecular Pharmacology August 1990, 38 (2) 261-266;

  2. Campbell, M D

    1. Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells.
      M D Campbell, S Subramaniam, M I Kotlikoff, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1990, 38 (2) 282-288;

  3. Camus, J

    1. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology August 1990, 38 (2) 267-273;

  4. Christophe, J

    1. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology August 1990, 38 (2) 267-273;

E

  1. Eriksson, S

    1. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
      Y Törnevik and S Eriksson
      Molecular Pharmacology August 1990, 38 (2) 237-243;

F

  1. Fluharty, S J

    1. Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells.
      M D Campbell, S Subramaniam, M I Kotlikoff, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1990, 38 (2) 282-288;

G

  1. Gerhardt, M A

    1. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
      M A Gerhardt, S M Wade and R R Neubig
      Molecular Pharmacology August 1990, 38 (2) 214-221;

  2. Guengerich, F P

    1. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;

  3. Gustafsson, J A

    1. Growth hormone regulation of the cytochrome P-450IIC subfamily in the rat: inductive, repressive, and transcriptional effects on P-450f (IIC7) and P-450PB1 (IIC6) gene expression.
      S Westin, A Ström, J A Gustafsson and P G Zaphiropoulos
      Molecular Pharmacology August 1990, 38 (2) 192-197;

I

  1. Imai, S

    1. Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
      Y Kitamura, S Imai, R Matsueda and Y Nomura
      Molecular Pharmacology August 1990, 38 (2) 184-191;

  2. Iwasaki, M

    1. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;

J

  1. Jacobson, K A

    1. Glycoprotein nature of the A2-adenosine receptor binding subunit.
      W W Barrington, K A Jacobson and G L Stiles
      Molecular Pharmacology August 1990, 38 (2) 177-183;

  2. Johnson, B G

    1. Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.
      D D Schoepp, B G Johnson, E C Smith and L A McQuaid
      Molecular Pharmacology August 1990, 38 (2) 222-228;

K

  1. Kemp, D E

    1. Kainate receptors coupled to the evoked release of [3H]-gamma-aminobutyric acid from striatal neurons in primary culture: potentiation by lithium ions.
      S Weiss, D E Kemp, L Bauce and F W Tse
      Molecular Pharmacology August 1990, 38 (2) 229-236;

  2. Kitamura, Y

    1. Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
      Y Kitamura, S Imai, R Matsueda and Y Nomura
      Molecular Pharmacology August 1990, 38 (2) 184-191;

  3. Klueppelberg, U G

    1. Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
      U G Klueppelberg, X Molero, R W Barrett and L J Miller
      Molecular Pharmacology August 1990, 38 (2) 159-163;

  4. Kotlikoff, M I

    1. Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells.
      M D Campbell, S Subramaniam, M I Kotlikoff, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1990, 38 (2) 282-288;

L

  1. Linden, J

    1. Interaction of purified bovine brain A1-adenosine receptors with guanine nucleotide-binding proteins of human platelet membranes following reconstitution.
      R Munshi and J Linden
      Molecular Pharmacology August 1990, 38 (2) 170-176;

M

  1. Mailer, C

    1. Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide.
      J S Woods, C A Calas, L D Aicher, B H Robinson and C Mailer
      Molecular Pharmacology August 1990, 38 (2) 253-260;

  2. Matsueda, R

    1. Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
      Y Kitamura, S Imai, R Matsueda and Y Nomura
      Molecular Pharmacology August 1990, 38 (2) 184-191;

  3. McQuaid, L A

    1. Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.
      D D Schoepp, B G Johnson, E C Smith and L A McQuaid
      Molecular Pharmacology August 1990, 38 (2) 222-228;

  4. Miller, L J

    1. Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
      U G Klueppelberg, X Molero, R W Barrett and L J Miller
      Molecular Pharmacology August 1990, 38 (2) 159-163;

  5. Minneman, K P

    1. Pertussis toxin inhibits norepinephrine-stimulated inositol phosphate formation in primary brain cell cultures.
      K M Wilson and K P Minneman
      Molecular Pharmacology August 1990, 38 (2) 274-281;

  6. Molero, X

    1. Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells.
      U G Klueppelberg, X Molero, R W Barrett and L J Miller
      Molecular Pharmacology August 1990, 38 (2) 159-163;

  7. Molowa, D T

    1. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;

  8. Munshi, R

    1. Interaction of purified bovine brain A1-adenosine receptors with guanine nucleotide-binding proteins of human platelet membranes following reconstitution.
      R Munshi and J Linden
      Molecular Pharmacology August 1990, 38 (2) 170-176;

N

  1. Neubig, R R

    1. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
      M A Gerhardt, S M Wade and R R Neubig
      Molecular Pharmacology August 1990, 38 (2) 214-221;

  2. Nomura, Y

    1. Effects of sulfhydryl-modifying reagents, 3-nitro-2-pyridinesulfenyl compounds, on the coupling between inhibitory receptors and GTP-binding proteins Gi/Go in rat brain membranes.
      Y Kitamura, S Imai, R Matsueda and Y Nomura
      Molecular Pharmacology August 1990, 38 (2) 184-191;

R

  1. Raucy, J L

    1. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;

  2. Rauscher, F J

    1. Characterization of auromomycin-resistant hamster cell mutants that display a multidrug resistance phenotype.
      F J Rauscher, T A Beerman and R M Baker
      Molecular Pharmacology August 1990, 38 (2) 198-206;

  3. Resink, T J

    1. Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance.
      T J Resink, T Scott-Burden, C Boulanger, E Weber and F R Bühler
      Molecular Pharmacology August 1990, 38 (2) 244-252;

  4. Robinson, B H

    1. Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide.
      J S Woods, C A Calas, L D Aicher, B H Robinson and C Mailer
      Molecular Pharmacology August 1990, 38 (2) 253-260;

S

  1. Sari, M A

    1. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;

  2. Schoepp, D D

    1. Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.
      D D Schoepp, B G Johnson, E C Smith and L A McQuaid
      Molecular Pharmacology August 1990, 38 (2) 222-228;

  3. Scott-Burden, T

    1. Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance.
      T J Resink, T Scott-Burden, C Boulanger, E Weber and F R Bühler
      Molecular Pharmacology August 1990, 38 (2) 244-252;

  4. Smith, E C

    1. Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid.
      D D Schoepp, B G Johnson, E C Smith and L A McQuaid
      Molecular Pharmacology August 1990, 38 (2) 222-228;

  5. Stiles, G L

    1. Glycoprotein nature of the A2-adenosine receptor binding subunit.
      W W Barrington, K A Jacobson and G L Stiles
      Molecular Pharmacology August 1990, 38 (2) 177-183;

  6. Ström, A

    1. Growth hormone regulation of the cytochrome P-450IIC subfamily in the rat: inductive, repressive, and transcriptional effects on P-450f (IIC7) and P-450PB1 (IIC6) gene expression.
      S Westin, A Ström, J A Gustafsson and P G Zaphiropoulos
      Molecular Pharmacology August 1990, 38 (2) 192-197;

  7. Subramaniam, S

    1. Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells.
      M D Campbell, S Subramaniam, M I Kotlikoff, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1990, 38 (2) 282-288;

T

  1. Tastenoy, M

    1. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology August 1990, 38 (2) 267-273;

  2. Törnevik, Y

    1. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
      Y Törnevik and S Eriksson
      Molecular Pharmacology August 1990, 38 (2) 237-243;

  3. Tse, F W

    1. Kainate receptors coupled to the evoked release of [3H]-gamma-aminobutyric acid from striatal neurons in primary culture: potentiation by lithium ions.
      S Weiss, D E Kemp, L Bauce and F W Tse
      Molecular Pharmacology August 1990, 38 (2) 229-236;

V

  1. Vandenbranden, M

    1. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;

W

  1. Wade, S M

    1. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
      M A Gerhardt, S M Wade and R R Neubig
      Molecular Pharmacology August 1990, 38 (2) 214-221;

  2. Waelbroeck, M

    1. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
      M Waelbroeck, M Tastenoy, J Camus and J Christophe
      Molecular Pharmacology August 1990, 38 (2) 267-273;

  3. Weber, E

    1. Internalization of endothelin by cultured human vascular smooth muscle cells: characterization and physiological significance.
      T J Resink, T Scott-Burden, C Boulanger, E Weber and F R Bühler
      Molecular Pharmacology August 1990, 38 (2) 244-252;

  4. Weiss, S

    1. Kainate receptors coupled to the evoked release of [3H]-gamma-aminobutyric acid from striatal neurons in primary culture: potentiation by lithium ions.
      S Weiss, D E Kemp, L Bauce and F W Tse
      Molecular Pharmacology August 1990, 38 (2) 229-236;

  5. Westin, S

    1. Growth hormone regulation of the cytochrome P-450IIC subfamily in the rat: inductive, repressive, and transcriptional effects on P-450f (IIC7) and P-450PB1 (IIC6) gene expression.
      S Westin, A Ström, J A Gustafsson and P G Zaphiropoulos
      Molecular Pharmacology August 1990, 38 (2) 192-197;

  6. Williamson, J R

    1. Cyclic AMP inhibits inositol polyphosphate production and calcium mobilization in neuroblastoma X glioma NG108-15 cells.
      M D Campbell, S Subramaniam, M I Kotlikoff, J R Williamson and S J Fluharty
      Molecular Pharmacology August 1990, 38 (2) 282-288;

  7. Wilson, K M

    1. Pertussis toxin inhibits norepinephrine-stimulated inositol phosphate formation in primary brain cell cultures.
      K M Wilson and K P Minneman
      Molecular Pharmacology August 1990, 38 (2) 274-281;

  8. Woods, J S

    1. Stimulation of porphyrinogen oxidation by mercuric ion. I. Evidence of free radical formation in the presence of thiols and hydrogen peroxide.
      J S Woods, C A Calas, L D Aicher, B H Robinson and C Mailer
      Molecular Pharmacology August 1990, 38 (2) 253-260;
    2. Stimulation of porphyrinogen oxidation by mercuric ion. II. Promotion of oxidation from the interaction of mercuric ion, glutathione, and mitochondria-generated hydrogen peroxide.
      J S Woods, C A Calas and L D Aicher
      Molecular Pharmacology August 1990, 38 (2) 261-266;

  9. Wrighton, S A

    1. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
      S A Wrighton, W R Brian, M A Sari, M Iwasaki, F P Guengerich, J L Raucy, D T Molowa and M Vandenbranden
      Molecular Pharmacology August 1990, 38 (2) 207-213;

Z

  1. Zaphiropoulos, P G

    1. Growth hormone regulation of the cytochrome P-450IIC subfamily in the rat: inductive, repressive, and transcriptional effects on P-450f (IIC7) and P-450PB1 (IIC6) gene expression.
      S Westin, A Ström, J A Gustafsson and P G Zaphiropoulos
      Molecular Pharmacology August 1990, 38 (2) 192-197;
Back to top

In this issue